Connect with us

Technology

Leading Proxy Advisor ISS Recommends Nuvei Shareholders Vote “FOR” Arrangement

Published

on

Shareholders are encouraged to vote “FOR” the special resolution approving the Arrangement in advance of the June 14, 2024 at 10:00 a.m. (Eastern time) deadlineFor more information go to www.NuveiPOA.com

MONTREAL, May 29, 2024 /PRNewswire/ — Nuvei Corporation (“Nuvei” or the “Company”) (Nasdaq: NVEI) (TSX: NVEI), today announced that proxy advisory firm Institutional Shareholder Services (“ISS”) has recommended that Nuvei shareholders vote FOR the previously announced statutory plan of arrangement (the “Arrangement”) involving the Company and Neon Maple Purchaser Inc. (the “Purchaser”), a newly-formed entity controlled by Advent International (“Advent”), pursuant to the provisions of the Canada Business Corporations Act.  Pursuant to the Arrangement, the Purchaser will acquire all the issued and outstanding subordinate voting shares (“Subordinate Voting Shares”) and multiple voting shares (“Multiple Voting Shares”) of the Company (collectively, the “Shares”) that are not Rollover Sharesi for a price of US$34.00 cash per Share. The special meeting of shareholders (the “Meeting”) to approve the Arrangement will be held on June 18, 2024 at 10:00 a.m. (Eastern time), in a virtual format at the following link: https://web.lumiagm.com/432819058.

In making its recommendation that Nuvei shareholders vote FOR the Arrangement, ISS stated:

“[T]he offer represents a meaningful premium to the unaffected price, the sale process (and valuation) appears reasonable in the circumstances, and there are downside risks of non-approval. As such, support for the proposal is warranted.””At present, while the company remains a growing business with some promise, there is little available evidence that management will be able to restore the company’s share price to levels seen two or three years ago in short order. Given the size of the premium and share price outperformance since the unaffected date, shareholders should probably not anticipate a sustained soft landing if the deal is rejected. On balance, in light of the foregoing considerations, shareholder support is warranted.”

The board of directors of the Company (the “Board”) has unanimously concluded (with interested directors abstaining from voting) that the Arrangement is in the best interests of the Company and its shareholders and recommends that shareholders vote FOR the special resolution approving the Arrangement. This recommendation follows the unanimous recommendation of a special committee of the Board which is comprised solely of independent directors and was formed in connection with the transaction (the “Special Committee”).

The Company’s management proxy circular and the Schedule 13E-3 required pursuant to the Rules under the U.S. Securities and Exchange Act of 1934, as amended, are available under Nuvei’s profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov.

Vote Today FOR the Special Resolution Approving the Arrangement

Your vote is important regardless of the number of Shares you own. If you are unable to be virtually present at the Meeting, we encourage you to submit your proxy or voting instruction form, so that your Shares can be voted at the Meeting in accordance with your instructions. To be counted at the Meeting, votes must be received by Nuvei’s transfer agent, TSX Trust Company, no later than 10:00 a.m. (Eastern time) on June 14, 2024, or, if the Meeting is adjourned or postponed, at least 48 hours (excluding Saturdays and holidays) prior to the commencement of the reconvened Meeting.

Shareholder Questions and Assistance

If you have any questions or require more information with respect to the procedures for voting, please contact our strategic advisor, Kingsdale Advisors, by telephone at 1 (888) 327-0819 (toll-free in North America) or at (416) 623-4173 (outside of North America), or by email at contactus@kingsdaleadvisors.com. For more information, please visit www.NuveiPOA.com.

About Nuvei

Nuvei (Nasdaq: NVEI) (TSX: NVEI) is the Canadian fintech company accelerating the business of clients around the world. Nuvei’s modular, flexible and scalable technology allows leading companies to accept next-gen payments, offer all payout options and benefit from card issuing, banking, risk and fraud management services. Connecting businesses to their customers in more than 200 markets, with local acquiring in 50 markets, 150 currencies and 700 alternative payment methods, Nuvei provides the technology and insights for customers and partners to succeed locally and globally with one integration.

Forward-Looking Information

This press release contains “forward-looking information” and “forward-looking statements” (collectively, “Forward-looking information”) within the meaning of applicable securities laws. This forward-looking information is identified by the use of terms and phrases such as “may”, “would”, “should”, “could”, “expect”, “intend”, “estimate”, “anticipate”, “plan”, “foresee”, “believe”, or “continue”, the negative of these terms and similar terminology, including references to assumptions, although not all forward-looking information contains these terms and phrases. Particularly, statements regarding the proposed transaction, including the proposed timing and various steps contemplated in respect of the transaction and statements regarding the plans, objectives, and intentions of Mr. Philip Fayer, Novacap, CDPQ or Advent are forward-looking information.

In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances.

Forward-looking information is based on management’s beliefs and assumptions and on information currently available to management, and although the forward-looking information contained herein is based upon what we believe are reasonable assumptions, investors are cautioned against placing undue reliance on this information since actual results may vary from the forward-looking information.

Forward-looking information involves known and unknown risks and uncertainties, many of which are beyond our control, that could cause actual results to differ materially from those that are disclosed in or implied by such forward-looking information. These risks and uncertainties include, but are not limited to, the risk factors described in greater detail under “Risk Factors” of the Company’s annual information form filed on March 5, 2024 and under “Risk Factors” of the Company’s management’s discussion & analysis for the three months ended March 31, 2024. These risks and uncertainties further include (but are not limited to) as concerns the transaction, the failure of the parties to obtain the necessary shareholder, regulatory and court approvals or to otherwise satisfy the conditions to the completion of the transaction, failure of the parties to obtain such approvals or satisfy such conditions in a timely manner, significant transaction costs or unknown liabilities, failure to realize the expected benefits of the transaction, and general economic conditions. Failure to obtain the necessary shareholder, regulatory and court approvals, or the failure of the parties to otherwise satisfy the conditions to the completion of the transaction or to complete the transaction, may result in the transaction not being completed on the proposed terms, or at all. In addition, if the transaction is not completed, and the Company continues as a publicly-traded entity, there are risks that the announcement of the proposed transaction and the dedication of substantial resources of the Company to the completion of the transaction could have an impact on its business and strategic relationships (including with future and prospective employees, customers, suppliers and partners), operating results and activities in general, and could have a material adverse effect on its current and future operations, financial condition and prospects. Furthermore, in certain circumstances, the Company may be required to pay a termination fee pursuant to the terms of the Arrangement Agreement which could have a material adverse effect on its financial position and results of operations and its ability to fund growth prospects and current operations.

Consequently, all of the forward-looking information contained herein is qualified by the foregoing cautionary statements, and there can be no guarantee that the results or developments that we anticipate will be realized or, even if substantially realized, that they will have the expected consequences or effects on our business, financial condition or results of operation. Unless otherwise noted or the context otherwise indicates, the forward-looking information contained herein represents our expectations as of the date hereof or as of the date it is otherwise stated to be made, as applicable, and is subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or amend such forward-looking information whether as a result of new information, future events or otherwise, except as may be required by applicable law.

For further information, please contact:

Investors

Kingsdale Advisors
contactus@kingsdaleadvisors.com

Chris Mammone, Head of Investor Relations
IR@nuvei.com

Media

Joel Shaffer
FGS Longview
Joel.shaffer@fgslongview.com

NVEI-IR

i Philip Fayer, certain investment funds managed by Novacap Management Inc. (collectively, “Novacap”)  and CDPQ (together with entities they control directly or indirectly, collectively, the “Rollover Shareholders”) have agreed to roll approximately 95%, 65% and 75%, respectively, of their Shares (the “Rollover Shares”) and are expected to receive in aggregate approximately US$563 million in cash for the Shares sold on closing (percentages and amount of expected cash proceeds are based on current assumed cash position and are subject to change as a result of cash generated before closing). Philip Fayer, Novacap and CDPQ are expected to indirectly own or control approximately 24%, 18% and 12%, respectively, of the equity in the resulting private company.

View original content to download multimedia:https://www.prnewswire.com/news-releases/leading-proxy-advisor-iss-recommends-nuvei-shareholders-vote-for-arrangement-302158288.html

SOURCE Nuvei

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Equifax Announces Participation in Upcoming Investor Conferences

Published

on

By

ATLANTA, May 1, 2026 /PRNewswire/ — Equifax® (NYSE: EFX) will participate in several upcoming investor conferences in May and June.

Mark W. Begor, Chief Executive Officer, and John Gamble, Chief Financial Officer, will participate in the Baird 2026 Global Consumer, Technology & Services Conference on Tuesday, June 2, 2026 including participation in a Fireside Chat at 10:50 a.m., Eastern Time and the William Blair 2026 Growth Stock Conference on Wednesday, June 3, 2026, including participation in a Fireside Chat at 9:40 a.m., Eastern Time. 

The company invites investors to join a live webcast of these Fireside Chat events at: https://investor.equifax.com/news-events/ir-calendar. A replay of these Fireside Chats will be available within 24 hours after the event on the company’s Investor Relations website. 

John Gamble, Chief Financial Officer, will attend the Bernstein Annual Strategic Decisions Conference on Wednesday, May 27, 2026. 

Trevor Burns, Senior Vice President of Corporate Investor Relations, will attend the Barclays Americas Select Franchise Conference on Tuesday, May 5, 2026, the virtual Needham Technology, Media, & Consumer Conference on Thursday, May 14, 2026, and the J.P. Morgan All Stars Canada Conference on Tuesday, June 2, 2026.

ABOUT EQUIFAX INC.
At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.com.

FOR MORE INFORMATION:
Molly Clegg for Equifax
mediainquiries@equifax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/equifax-announces-participation-in-upcoming-investor-conferences-302760292.html

SOURCE Equifax Inc.

Continue Reading

Technology

Cisco Schedules Conference Call for Q3 Fiscal Year 2026 Financial Results

Published

on

By

SAN JOSE, Calif., May 1, 2026 /PRNewswire/ — Cisco (NASDAQ: CSCO) has scheduled a conference call for Wednesday, May 13, 2026, at 1:30 PM (PT); 4:30 PM (ET) to announce its third quarter fiscal year 2026 financial results for the period ending Saturday, April 25, 2026.

Financial results will be released over PR Newswire via US National and European Financial distribution, after the close of the market on Wednesday, May 13, 2026. Cisco’s quarterly earnings press release will be posted at https://newsroom.cisco.com.

Date:
Wednesday, May 13, 2026

Time:
1:30 PM (PT); 4:30 PM (ET)

To Listen via Telephone: 
888-848-6507
212-519-0847 (for International Callers)

To Listen via the Internet: 
We are pleased to offer a live and replay audio broadcast of the conference call with corresponding slides at https://investor.cisco.com.

The conference call will also be livestreamed on YouTube & LinkedIn.

Replay:
A telephone playback of the Q3 FY2026 conference call is scheduled to be available beginning at 4:00 PM (PT) on May 13, 2026, through 10:00 PM (PT) May 19, 2026. The replay will be accessible by calling 800-839-2232 (International callers: 203-369-3662). The call runs 24 hours/day, including weekends. An archived version of the webcast will be available on Cisco’s Investor Relations website at https://investor.cisco.com.

About Cisco

Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has securely connected the world. With its industry leading AI-powered solutions and services, Cisco enables its customers, partners and communities to unlock innovation, enhance productivity and strengthen digital resilience. With purpose at its core, Cisco remains committed to creating a more connected and inclusive future for all. Discover more on The Newsroom and follow us on X at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco’s trademarks can be found at http://www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word ‘partner’ does not imply a partnership relationship between Cisco and any other company.

Investor Relations Contact: 

Press Contact: 

Sami Badri

Britt Stagnaro

Cisco

Cisco

sambadri@cisco.com

media_pr@external.cisco.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cisco-schedules-conference-call-for-q3-fiscal-year-2026-financial-results-302760253.html

SOURCE Cisco Systems, Inc.

Continue Reading

Technology

Essen Health Care Launches RADIN Health All-In-One RIS and PACS Cloud Platform

Published

on

By

SHERIDAN, Wyo.  , May 1, 2026 /PRNewswire/ — Essen Health Care is thrilled to announce a significant advancement in our commitment to providing exceptional patient care and cutting-edge medical services: the introduction of RADIN Health.

This initiative represents a major investment in the future of medical imaging, solidifying our dedication to offering the highest quality diagnostic services and an unparalleled patient and provider experience within the communities we serve.

“RADIN Health is more than just a technology upgrade; it is a fundamental pillar of Essen Health Care’s strategy to deliver accessible, efficient, and superior diagnostic imaging services to our community”, says Jonathan Khodadadian, MD, Medical Director, Specialty Division, Essen Health Care.  

The RADIN Platform: A Commitment to Innovation

RADIN Health is powered by an advanced, end-to-end, all-in-one RIS and PACS radiology cloud platform. This state-of-the-art system has been meticulously designed to revolutionize the imaging process, ensuring efficiency, accuracy, and accessibility for everyone involved.

Transforming the Patient and Provider Journey

The RADIN platform utilizes sophisticated, state-of-the-art artificial intelligence (AI) across multiple facets of the imaging journey:

Enhanced Patient and Provider Engagement: AI tools, patient, and referring physician portals streamline orders for appointments and communication, ensuring the external workflow process is easy, transparent, and accessible.Easy Image and Report Sharing: The cloud application allows easy electronic sharing and access of images and reports for providers and patients.Ease of Scheduling: The system simplifies the typically complex scheduling process, allowing for quick, convenient, and accurate appointment booking.Optimized Physician Reporting: AI assists in the generation of detailed, rapid, and precise physician reports, ensuring healthcare providers receive the critical information they need promptly to guide treatment decisions.

Driving Efficiency and Quality

The RADIN platform elevates the operational standards of imaging services. By reducing manual steps throughout the process—from order entry to image archival—and improving overall system efficiency, the platform ensures:

Timely Imaging Services: Quicker turnaround times mean patients receive their diagnoses faster, enabling earlier treatment planning.High-Quality Diagnostics: The system supports consistent, high-fidelity imaging quality, leading to more accurate diagnoses.Patient Follow-up Tracking: Recommended patient follow-up scans are automated and track recommendations for important, abnormal or inconclusive findings.Compliance and Best Practices: The cloud platform is built to support stringent regulatory compliance and adherence to the highest industry standards and best practices, giving both providers and patients confidence in the care received.

Essen Health Care is an integrated, multi-specialty healthcare delivery organization with more than 25 years of experience providing quality, compassionate, and accessible medical care to communities across New York. Offering house calls, urgent care, primary care, and specialty services, Essen Health Care is committed to advancing health equity and improving health outcomes for all patients. For more information, visit https://www.essenhealthcare.com

RADIN HealthⓇ is focused on developing SaaS products that enhance the efficiency, productivity, and scalability of hospitals, imaging centers and radiology practices. Utilizing artificial intelligence (AI), machine learning (ML), and natural language processing (NLP), Radin Health offers a Cloud-based, Serverless, All-In-One RIS, PACS, Dictation AI®, and Select® Workflow Management Solution. For more information, visit www.radinhealth.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/essen-health-care-launches-radin-health-all-in-one-ris-and-pacs-cloud-platform-302760463.html

SOURCE Radin LLC

Continue Reading

Trending